1. Franchi A. Epidemiology and classification of bone tumors. Clin Cases Miner Bone Metab. 2012;9(2):92–5.
2. Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment—where do we stand? A state of the art review. Cancer Treat Rev. 2014;40(4):523–32.
3. Friebele JC, Peck J, Pan X, Abdel-Rasoul M, Mayerson JL. Osteosarcoma: a meta-analysis and review of the literature. Am J Orthop (Belle Mead NJ). 2015;44(12):547–53.
4. Patrascu JM, Vermesan D, Mioc ML, Lazureanu V, Florescu S, Tarullo A, Tatullo M, Abbinante A, Caprio M, Cagiano R, Haragus H. Musculo-skeletal tumors incidence and surgical treatment—a single center 5-year retrospective. Eur Rev Med Pharmacol Sci. 2014;18(24):3898–901.
5. Folpe AL, Lyles RH, Sprouse JT, Conrad EU 3rd, Eary JF. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res. 2000;6(4):1279–87.